secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2025-04-02T23:59:59+00:00
Accession:  0001628280-25-016066
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio prices $5M public offering of shares and warrants; net proceeds ~$4.2M
------------------------------------------------------------------------------

- Priced public offering of 1,388,888 units at $3.60 each (share or pre-funded warrant plus Series E-1, E-2, E-3 warrants).
- Gross proceeds ~$5.0M; net ~$4.2M after 7% agent fee and expenses; closing expected April 2, 2025.
- Warrants exercisable at $3.20; if fully cash-exercised, additional gross proceeds ~$13.3M.
- Net proceeds for working capital and product development; cash runway expected only through Q3 2025.
- H.C. Wainwright acting as placement agent; receives warrants for 97,222 shares at $4.50 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000162828025016066/0001628280-25-016066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000162828025016066/val-20250401.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-016066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer